PET (Positron Emission Tomography)/Public Speaking Study With A Combination Of 2 Medications In Social Anxiety Patients

Clinical trial NCT00343707 · COMPLETED

Trial details

NCT number: NCT00343707
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Depressive Disorder and Anxiety Disorders

Start date: 2004-11-01
Primary completion: 2005-11-01
Enrollment: 72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.